Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Usa Thisyakorn & Terapong Tantawichien. (2020) Dengue vaccine: a key for prevention. Expert Review of Vaccines 19:6, pages 499-506.
Read now
Read now
Annelies Wilder-Smith & In-Kyu Yoon. (2016) Edging closer towards the goal of a dengue vaccine. Expert Review of Vaccines 15:4, pages 433-435.
Read now
Read now
Valérie R. Louis, Carlos Alberto Montenegro Quiñonez, Pad Kusumawathie, Paba Palihawadana, Sakoo Janaki, Yesim Tozan, Ruwan Wijemuni, Annelies Wilder-Smith & Hasitha A. Tissera. (2016) Characteristics of and factors associated with dengue vector breeding sites in the City of Colombo, Sri Lanka. Pathogens and Global Health 110:2, pages 79-86.
Read now
Read now
Articles from other publishers (15)
Josephine Diony Nanda, Chiau-Jing Jung, Rahmat Dani Satria, Ming-Kai Jhan, Ting-Jing Shen, Po-Chun Tseng, Yung-Ting Wang, Tzong-Shiann Ho & Chiou-Feng Lin. (2021) Serum IL-18 Is a Potential Biomarker for Predicting Severe Dengue Disease Progression. Journal of Immunology Research 2021, pages 1-15.
Crossref
Crossref
Jovin J. Y. Choo, Laura J. Vet, Christopher L. D. McMillan, Jessica J. Harrison, Connor A. P. Scott, Alexandra C. I. Depelsenaire, Germain J. P. Fernando, Daniel Watterson, Roy A. Hall, Paul R. Young, Jody Hobson-Peters & David A. Muller. (2021) A chimeric dengue virus vaccine candidate delivered by high density microarray patches protects against infection in mice. npj Vaccines 6:1.
Crossref
Crossref
Marc F.D. Baay, Thomas L. Richie, Pieter Neels, Marco Cavaleri, Roma Chilengi, David Diemert, Stephen L. Hoffman, Robert Johnson, Beth D. Kirkpatrick, Ivana Knezevic, Matthew Laurens, Helen McShane, Patricia Njuguna, Anastazia Older Aguilar, Andrew J. Pollard, Mark Riddle, Robert Sauerwein, James Southern, David Tribble & Adrian Wildfire. (2019) Human challenge trials in vaccine development, Rockville, MD, USA, September 28–30, 2017. Biologicals 61, pages 85-94.
Crossref
Crossref
Polly Lee, Apple C.M. Yeung, Zigui Chen, Martin C.W. Chan, Kin Ho Sze & Paul K.S. Chan. (2018) Age-specific seroprevalence of dengue infection in Hong Kong. Journal of Medical Virology 90:9, pages 1427-1430.
Crossref
Crossref
Leah Mathias, Vito Baraka, Anitha Philbert, Ester Innocent, Filbert Francis, Gamba Nkwengulila & Eliningaya J. Kweka. (2017) Habitat productivity and pyrethroid susceptibility status of Aedes aegypti mosquitoes in Dar es Salaam, Tanzania. Infectious Diseases of Poverty 6:1.
Crossref
Crossref
Diogo M. Magnani, Cassia G. T. Silveira, Michael J. Ricciardi, Lucas Gonzalez-Nieto, Núria Pedreño-Lopez, Varian K. Bailey, Martin J. Gutman, Helen S. Maxwell, Aline Domingues, Priscilla R. Costa, Lilian Ferrari, Raphaella Goulart, Mauricio A. Martins, José M. Martinez-Navio, Sebastian P. Fuchs, Jorge Kalil, Maria do Carmo Timenetsky, Jens Wrammert, Stephen S. Whitehead, Dennis R. Burton, Ronald C. Desrosiers, Esper G. Kallas & David I. Watkins. (2017) Potent Plasmablast-Derived Antibodies Elicited by the National Institutes of Health Dengue Vaccine. Journal of Virology 91:22.
Crossref
Crossref
Maria Eugenia Toledo, Veerle Vanlerberghe, Julio Popa Rosales, Mayelin Mirabal, Pedro Cabrera, Viviana Fonseca, Tania Gómez Padrón, Mirtha Pérez Menzies, Domingo Montada & Patrick Van der Stuyft. (2017) The additional benefit of residual spraying and insecticide-treated curtains for dengue control over current best practice in Cuba: Evaluation of disease incidence in a cluster randomized trial in a low burden setting with intensive routine control. PLOS Neglected Tropical Diseases 11:11, pages e0006031.
Crossref
Crossref
Ee Leen Pang & Hwei-San Loh. (2017) Towards development of a universal dengue vaccine – How close are we?. Asian Pacific Journal of Tropical Medicine 10:3, pages 220-228.
Crossref
Crossref
Leslie Goo, Laura A. VanBlargan, Kimberly A. Dowd, Michael S. Diamond & Theodore C. Pierson. (2017) A single mutation in the envelope protein modulates flavivirus antigenicity, stability, and pathogenesis. PLOS Pathogens 13:2, pages e1006178.
Crossref
Crossref
Yie Hou Lee, Wei-Yee Leong & Annelies Wilder-Smith. (2016) Markers of dengue severity: a systematic review of cytokines and chemokines. Journal of General Virology 97:12, pages 3103-3119.
Crossref
Crossref
Annelies Wilder-Smith, Kirsten S. Vannice, Joachim Hombach, Jeremy Farrar & Terry Nolan. (2016) Population Perspectives and World Health Organization Recommendations for CYD-TDV Dengue Vaccine. Journal of Infectious Diseases 214:12, pages 1796-1799.
Crossref
Crossref
José Lourenço & Mario Recker. (2016) Dengue serotype immune-interactions and their consequences for vaccine impact predictions. Epidemics 16, pages 40-48.
Crossref
Crossref
Mario Recker, Kirsten Vannice, Joachim Hombach, Mark Jit & Cameron P. Simmons. (2016) Assessing dengue vaccination impact: Model challenges and future directions. Vaccine 34:38, pages 4461-4465.
Crossref
Crossref
Annelies Wilder-Smith & Peter Byass. (2016) The elusive global burden of dengue. The Lancet Infectious Diseases 16:6, pages 629-631.
Crossref
Crossref
Bradford D. Gessner & Annelies Wilder-Smith. (2016) Estimating the public health importance of the CYD-tetravalent dengue vaccine: Vaccine preventable disease incidence and numbers needed to vaccinate. Vaccine 34:20, pages 2397-2401.
Crossref
Crossref